Jean‐Claude Tardif
United States Nuclear Regulatory Commission(US)Montreal Heart Institute(CA)Health Innovations (United States)(US)Cegep Edouard Montpetit(CA)Université de Montréal(CA)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Cardiac Imaging and Diagnostics, Cardiovascular Health and Risk Factors, Coronary Interventions and Diagnostics, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia(2018)3,144 cited
- → Effects of Torcetrapib in Patients at High Risk for Coronary Events(2007)3,113 cited
- → Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome(2015)2,293 cited
- → Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis(2006)2,023 cited
- → Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome(2012)2,011 cited
- → Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011)(2012)1,738 cited